While REMS programs are intended to mitigate risk, a number of factors can make proper deployment difficult. This week’s ISMP featured newsletter article, part one of a two-part series, highlights some of the REMS-related problems reported to ISMP: https://www.ismp.org/node/87562
MSOS News
Post date: 1 year 5 months ago
ISMP is conducting a short survey to get a sense of the current level of implementation of the 2022-2023 Targeted Medication Safety Best Practices for Hospitals. We would very much appreciate your participation in this survey. Please complete this survey online by June 30, 2023, by visiting: www.ismp.org/ext/1164. The findings will also be described when introducing the new 2024-2025 Targeted Medication Safety Best Practices for Hospitals early in 2024.
Post date: 1 year 5 months ago
The third episode ISMP’s medication safety podcast series focuses on how to reduce the risk of patient harm and medication errors associated with inappropriate polypharmacy. To watch: https://www.ismp.org/events/perils-polypharmacy
Post date: 1 year 5 months ago
This week’s ISMP featured newsletter article provides recommendations for preventing errors when pediatric patients need to be treated in settings that are not designated solely for children: https://www.ismp.org/node/82964
Post date: 1 year 5 months ago
An International Medication Safety Network (IMSN) special interest group chaired by ISMP recently published recommendations for global implementation of safe oxytocin use practices: https://www.intmedsafe.net/imsn-oxytocin-sig-issues-recommendations-for-...